- Home
- PCVX vs WFRD Comparison
PCVX vs WFRD Comparison
Compare PCVX & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | WFRD |
|---|---|---|
| Founded | 2013 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | WFRD |
|---|---|---|
| Price | $47.86 | $87.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $105.00 | $93.22 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 02-24-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 1.14% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.52 |
| Revenue | N/A | ★ $4,970,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.90 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.66 | $36.74 |
| 52 Week High | $93.77 | $91.23 |
Technical Indicators
Market Signals| Indicator | PCVX | WFRD |
|---|---|---|
| Relative Strength Index (RSI) | 59.10 | 61.84 |
| Support Level | $44.57 | $85.57 |
| Resistance Level | $47.72 | $90.93 |
| Average True Range (ATR) | 2.00 | 2.62 |
| MACD | 0.10 | 0.37 |
| Stochastic Oscillator | 75.11 | 72.59 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About WFRD Weatherford International plc
Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.